摘要
以2015-2019年A股医疗制造业上市公司为研究对象,将内部控制质量作为调节变量,通过构建多元线性回归模型和分位数回归模型探究内部控制质量、研发投入对公司财务绩效的影响。实证结果表明:扩大研发投入规模以及提升内部控制质量均能够显著地提升公司财务绩效。研发投入对于公司财务绩效的影响具有滞后性;在内部控制的调节作用下,研发投入可以更有效地转化为财务绩效,对于盈利能力较差的公司效果更显著。制定适宜的内部控制制度和合理的科研计划可以提升公司财务绩效。
Taking A-share medical manufacturing listed companies from 2015 to 2019 as the research object,taking the quality of internal control as the adjusting variable,the impact of internal control quality and R&D investment on the company’s financial performance is explored by constructing multiple linear regression model and quantile regression model.The empirical results show that expanding the scale of R&D investment and improving the quality of internal control can significantly promote the level of corporate financial performance.The impact of R&D investment on the company’s financial performance lags behind.Under the regulation of internal control,R&D investment can be more effectively transformed into financial performance,especially for companies with poor profitability.Making appropriate internal control system and reasonable scientific research plan can improve the company’s financial performance.
作者
王宏新
姜楠
WANG Hongxin;JIANG Nan(School of Business Administration,Liaoning Technical University,Huludao 125105,China)
出处
《辽宁工程技术大学学报（社会科学版）》
2022年第1期28-35,75,共9页
Journal of Liaoning Technical University(Social Science Edition)
关键词
医疗制造业
内部控制质量
研发投入
财务绩效
medical manufacturing
internal control quality
R&D investment
financial performance
作者简介
王宏新(1970-),女,吉林公主岭人,博士,副教授,主要从事审计与内部控制方面的研究。
